MARTON MEDICAL PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: P81054 | BLACKPOOL, FY3 9ES
Showing results 151-200 of 657
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Perindopril erbumine | 278 | 8,760 | £776 | -47.6% ▼ |
| Memantine hydrochloride | 277 | 7,460 | £1.3K | -16.1% ▼ |
| 270 | 285 | £1.6K | +14.3% ▲ | |
| Trazodone hydrochloride | 269 | 24.2K | £1.3K | +31.6% ▲ |
| Sulfasalazine | 267 | 39.4K | £5.9K | +105.1% ▲ |
| Fluticasone propionate (Nasal) | 262 | 751 | £2.8K | +80.0% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 256 | 21.0K | £856 | -16.5% ▼ |
| Latanoprost | 256 | 3,120 | £1.1K | -47.3% ▼ |
| Melatonin | 254 | 16.6K | £3.2K | -23.6% ▼ |
| 252 | 2,664 | £1.4K | +1.0% vs avg | |
| Rivaroxaban | 250 | 7,668 | £4.9K | -59.1% ▼ |
| Loperamide hydrochloride | 247 | 17.5K | £467 | +6.1% ▲ |
| Timolol and bimatoprost | 247 | 1,878 | £3.3K | +62.8% ▲ |
| Lisinopril | 242 | 8,638 | £186 | -77.9% ▼ |
| Tirzepatide | 232 | 232 | £22.1K | +19.5% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 231 | 22.2K | £1.5K | +28.6% ▲ |
| Beclometasone dipropionate | 231 | 237 | £713 | +7.4% ▲ |
| Olanzapine | 227 | 8,232 | £1.0K | -38.7% ▼ |
| Calcipotriol | 225 | 19.1K | £11.7K | +32.2% ▲ |
| Loratadine | 219 | 8,936 | £195 | +4.8% ▲ |
| Enalapril maleate | 217 | 9,296 | £379 | +20.8% ▲ |
| Glyceryl trinitrate | 215 | 218 | £492 | -9.1% ▼ |
| Oxybutynin | 212 | 12.1K | £3.9K | +11.3% ▲ |
| Biphasic insulin aspart | 211 | 1,095 | £6.5K | +107.8% ▲ |
| Nortriptyline | 210 | 12.7K | £436 | +44.3% ▲ |
| Clarithromycin | 210 | 4,982 | £1.0K | -14.4% ▼ |
| Aciclovir | 210 | 10.9K | £737 | +41.2% ▲ |
| Tadalafil | 209 | 3,864 | £688 | +22.9% ▲ |
| Lorazepam | 208 | 4,220 | £1.1K | +45.9% ▲ |
| Lacidipine | 207 | 6,174 | £567 | +73.2% ▲ |
| Ticagrelor | 207 | 12.2K | £11.9K | +143.4% ▲ |
| Progesterone | 206 | 13.4K | £2.8K | -50.8% ▼ |
| Docusate sodium | 201 | 17.5K | £1.2K | -45.8% ▼ |
| Mesalazine (Systemic) | 200 | 18.9K | £10.3K | -16.5% ▼ |
| Escitalopram | 200 | 5,418 | £319 | -29.7% ▼ |
| 195 | 14.0K | £1.3K | +313.0% ▲ | |
| Risperidone | 193 | 7,304 | £3.8K | -23.7% ▼ |
| Vortioxetine | 190 | 4,445 | £4.2K | +173.7% ▲ |
| Sacubitril/valsartan | 188 | 8,274 | £13.5K | -21.5% ▼ |
| Nifedipine | 183 | 11.4K | £2.2K | -2.4% ▼ |
| Pizotifen malate | 179 | 6,564 | £298 | +117.2% ▲ |
| Insulin detemir | 179 | 1,161 | £9.8K | +128.6% ▲ |
| Rizatriptan | 174 | 1,698 | £6.1K | +192.7% ▲ |
| Pantoprazole | 172 | 7,420 | £348 | -37.4% ▼ |
| Hypromellose | 168 | 1,910 | £396 | +26.8% ▲ |
| Valproic acid | 166 | 9,630 | £2.8K | +90.8% ▲ |
| Insulin degludec | 166 | 833 | £8.9K | +51.1% ▲ |
| Bumetanide | 162 | 11.6K | £1.1K | -40.5% ▼ |
| Quinine sulfate | 160 | 4,221 | £613 | -44.7% ▼ |
| 160 | 1,245 | £559 | -23.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.